| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/11/2010 | US20100286033 New cyclic peptide compounds |
| 11/11/2010 | US20100286032 Prodrugs of hiv protease inhibitors |
| 11/11/2010 | US20100286031 Antibiotic Formulations, Unit Doses, Kits and Methods |
| 11/11/2010 | US20100286029 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286028 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286027 Anti-bacterial compositions |
| 11/11/2010 | US20100286026 Novel protein |
| 11/11/2010 | US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 11/11/2010 | US20100286024 Insulinotropic compounds and uses thereof |
| 11/11/2010 | US20100286023 Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly |
| 11/11/2010 | US20100286022 Edible and biocompatible metal-organic frameworks |
| 11/11/2010 | US20100286020 milk protein composition and use thereof |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285527 Novel Polypeptide, cDNA Encoding the Same, and Use Thereof |
| 11/11/2010 | US20100285499 HUMAN p51 GENES AND GENE PRODUCTS THEREOF |
| 11/11/2010 | US20100285480 Tcl-1 gene and protein and related methods and compositions |
| 11/11/2010 | US20100285449 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 11/11/2010 | US20100285152 Composition for improving liver metabolism and diagnostic method |
| 11/11/2010 | US20100285145 Gpr 119 modulators |
| 11/11/2010 | US20100285143 Orally administerable solid pharmaceutical composition and a process thereof |
| 11/11/2010 | US20100285142 Method Of Making Particles For Use In A Pharmaceutical Composition |
| 11/11/2010 | US20100285137 Antibiotic/bone morphogenic protein formulation and method of treatment |
| 11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
| 11/11/2010 | US20100285131 Fgf21 mutants and uses thereof |
| 11/11/2010 | US20100285129 Novel agent for salting out active principles in dressings containing at least one of fatty substance |
| 11/11/2010 | US20100285118 Encapsulated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating |
| 11/11/2010 | US20100285116 Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells |
| 11/11/2010 | US20100285113 Enhanced stability of inverse thermal gelling composite hydrogels |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285104 Compositions and methods for the delivery of oxygen |
| 11/11/2010 | US20100285103 Medicament for treatment of tumors and the use thereof |
| 11/11/2010 | US20100285102 Colloidal collagen burn wound dressing produced from jellyfish |
| 11/11/2010 | US20100285097 Vaginal delivery system |
| 11/11/2010 | US20100285094 Polymeric compositions and methods of making and using thereof |
| 11/11/2010 | US20100285091 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers |
| 11/11/2010 | US20100285088 Tissue Adhesives and Sealants and Method for Their Use |
| 11/11/2010 | US20100285084 Antimicrobial coatings for medical devices and methods for making and using them |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285046 Nontoxic ricin mutant compositions and methods |
| 11/11/2010 | US20100285045 Novel Neurotrophic Factor Protein and Uses Thereof |
| 11/11/2010 | US20100285044 Method and compositions for treatment of cancers |
| 11/11/2010 | US20100285039 B7-H1 (CD274) Antagonists Induce Apoptosis of Tumor Cells |
| 11/11/2010 | US20100285038 Factor Involved in Metastasis and Uses Thereof |
| 11/11/2010 | US20100285033 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 11/11/2010 | US20100285032 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 11/11/2010 | US20100285031 Hox Compositions and Methods |
| 11/11/2010 | US20100285030 Antibodies to Ox-2/Cd200 and Uses Thereof |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100285028 Methods of treating coagulopathy |
| 11/11/2010 | US20100285024 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 11/11/2010 | US20100285020 Leukemic cell cns infiltration controlled by notch-induced chemotaxis |
| 11/11/2010 | US20100285017 Matriptase protein and uses thereof |
| 11/11/2010 | US20100285016 PRO34128 nucleic acids |
| 11/11/2010 | US20100285014 Immunoglobulin fusion proteins |
| 11/11/2010 | US20100285012 Methods and compositions for the treatment of cancers and pathogenic infections |
| 11/11/2010 | US20100285003 Therapeutic peptides and uses thereof |
| 11/11/2010 | US20100285001 Method and Compositions Related to Synergistic Responses to Oncogenic Mutations |
| 11/11/2010 | US20100285000 Use of vegfr-2 inhibitors for treating metastatic cancer |
| 11/11/2010 | US20100284998 Fibrin sealant |
| 11/11/2010 | US20100284997 Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| 11/11/2010 | US20100284996 Assays for Detection of Von Willebrand Factor (vWF) Multimers and for Degradation of vWF by Agents Such as Adamts13 and Related Methods |
| 11/11/2010 | US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof |
| 11/11/2010 | US20100284994 Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
| 11/11/2010 | US20100284993 Enhancing the Efficacy of Anti-Infective Therapeutics |
| 11/11/2010 | US20100284992 Phospholipase C and Method of Use |
| 11/11/2010 | US20100284991 Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases |
| 11/11/2010 | US20100284990 Compositions and Methods for Making Therapies Delivered by Viral Vectors Reversible for Safety and Allele-Specificity |
| 11/11/2010 | US20100284989 15-pgdh in colon cancer |
| 11/11/2010 | US20100284988 Utilization of shield effect for dopamine detection and reagent development |
| 11/11/2010 | US20100284987 Tablettable formulations of lipophilic health ingredients |
| 11/11/2010 | US20100284985 Composition |
| 11/11/2010 | US20100284984 Adenosine and its mimetics. modulators, transport inhibitors, and receptor agonists as a therapeutic tool to replace or improve the efficacy of deep brain stimulation |
| 11/11/2010 | US20100284983 Coenzyme q10-containing water-soluble composition and process for production thereof |
| 11/11/2010 | US20100284980 Nutritional Composition To Promote Healthy Development And Growth |
| 11/11/2010 | US20100284974 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 11/11/2010 | US20100284970 Benzimidazole modulators of h1 receptor and/or ns4b protein |
| 11/11/2010 | US20100284969 Methods and Compositions for Delivery of Medicaments to the Lungs |
| 11/11/2010 | US20100284968 Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases |
| 11/11/2010 | US20100284967 Modified phage for displaying post-translationally modified proteins and uses thereof |
| 11/11/2010 | US20100284966 Methods and Compositions for Managing Resistance of Hepatitis C Virus to Immunosuppressant |
| 11/11/2010 | US20100284965 Compositions and methods for adoptive and active immunotherapy |
| 11/11/2010 | US20100284964 Cancer therapy |
| 11/11/2010 | US20100284963 Growth regulatable recombinant bcg immunogenic compositions |
| 11/11/2010 | US20100284962 Modified tumor necrosis factor-beta |
| 11/11/2010 | US20100284961 MCP-1 binding nucleic acids |
| 11/11/2010 | US20100284958 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 11/11/2010 | US20100284944 Off-note blocking sensory organic compounds |
| 11/11/2010 | US20100284935 Markers and diagnostic methods for metastasis |
| 11/11/2010 | US20100284926 Use of g-csf for the treatment of stroke |
| 11/11/2010 | US20100284919 Injectable Radio-Opaque Compositions for Tissue Augmentation |
| 11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
| 11/11/2010 | US20100284915 Genes associated with chemotherapy response and uses thereof |
| 11/11/2010 | US20100284913 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | US20100284908 Proteins |
| 11/11/2010 | US20100284906 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 11/11/2010 | US20100284905 Methods and Agents for Inhibiting Tumor Growth by Targeting the SSDNA Replication Intermediate of Tumor Stem Cells |
| 11/11/2010 | US20100282247 Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin |
| 11/11/2010 | CA2761614A1 Human fg01 gene and its applications |